{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T12:40:28Z","timestamp":1776688828353,"version":"3.51.2"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,31]],"date-time":"2027-03-31T00:00:00Z","timestamp":1806451200000},"content-version":"am","delay-in-days":273,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jocn.2026.111997","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:36:51Z","timestamp":1774985811000},"page":"111997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical outcomes and MRI-based neurotoxicity assessment of elderly primary CNS lymphoma"],"prefix":"10.1016","volume":"149","author":[{"given":"Hiroaki","family":"Nagashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Yamanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Ikeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sasayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jocn.2026.111997_b0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3892\/ijo.2021.5180","article-title":"Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review)","volume":"58","author":"Liu","year":"2021","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jocn.2026.111997_b0010","article-title":"Age-related differences in primary central nervous system lymphomas based on the SEER database","volume":"12","author":"Lin","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jocn.2026.111997_b0015","doi-asserted-by":"crossref","DOI":"10.21037\/aol-20-43","article-title":"Primary central nervous system lymphoma in older adults and the rationale for maintenance strategies: a narrative review","volume":"5","author":"Tsang","year":"2021","journal-title":"Ann Lymphoma"},{"issue":"31","key":"10.1016\/j.jocn.2026.111997_b0020","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1200\/JCO.2013.50.4910","article-title":"Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome","volume":"31","author":"Morris","year":"2013","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jocn.2026.111997_b0025","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S1470-2045(10)70229-1","article-title":"High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial","volume":"11","author":"Thiel","year":"2010","journal-title":"Lancet Oncol"},{"issue":"24","key":"10.1016\/j.jocn.2026.111997_b0030","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2002.11.013","article-title":"Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10","volume":"20","author":"DeAngelis","year":"2002","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jocn.2026.111997_b0035","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2014-10-604561","article-title":"R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma","volume":"125","author":"Omuro","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jocn.2026.111997_b0040","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/cncr.23670","article-title":"Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy","volume":"113","author":"Ekenel","year":"2008","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.jocn.2026.111997_b0045","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2169\/internalmedicine.7805-21","article-title":"A Retrospective Analysis of R-MPV Plus Response-adapted Whole-brain Radiotherapy for Elderly Patients with Primary Central Nervous System Lymphoma","volume":"61","author":"Suzuki","year":"2022","journal-title":"Intern Med"},{"issue":"7","key":"10.1016\/j.jocn.2026.111997_b0050","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1200\/JOP.18.00180","article-title":"Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Summary","volume":"14","author":"Mohile","year":"2018","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.jocn.2026.111997_b0055","doi-asserted-by":"crossref","unstructured":"A. Morales-Martinez, F. Lozano-Sanchez, A. Duran-Pe\u00f1a, K. Hoang-Xuan, C. Houillier, Primary Central Nervous System Lymphoma in Elderly Patients: Management and Perspectives, Cancers (Basel) 13(14) (2021).","DOI":"10.3390\/cancers13143479"},{"issue":"10314","key":"10.1016\/j.jocn.2026.111997_b0060","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","article-title":"Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study","volume":"398","author":"Mohile","year":"2021","journal-title":"Lancet"},{"issue":"30","key":"10.1016\/j.jocn.2026.111997_b0065","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2007.12.5062","article-title":"Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma","volume":"25","author":"Shah","year":"2007","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.jocn.2026.111997_b0070","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1200\/JCO.2005.13.524","article-title":"Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma","volume":"23","author":"Abrey","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jocn.2026.111997_b0075","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.ijrobp.2024.11.088","article-title":"Consolidation Regimen and Cerebral Atrophy in Patients With Primary Central Nervous System Lymphoma","volume":"121","author":"Tringale","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.jocn.2026.111997_b0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5603\/RPOR.a2023.0028","article-title":"Radiotherapy for newly diagnosed primary central nervous system lymphoma: role and perspective","volume":"28","author":"Thomas","year":"2023","journal-title":"Rep Pract Oncol Radiother"},{"issue":"10","key":"10.1016\/j.jocn.2026.111997_b0085","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/archneur.62.10.1595","article-title":"Delayed neurotoxicity in primary central nervous system lymphoma","volume":"62","author":"Omuro","year":"2005","journal-title":"Arch Neurol"},{"issue":"11","key":"10.1016\/j.jocn.2026.111997_b0090","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/S2352-3026(17)30174-6","volume":"4","author":"Ferreri","year":"2017","journal-title":"Lancet Haematol"},{"issue":"9","key":"10.1016\/j.jocn.2026.111997_b0095","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/jjco\/hyaa073","article-title":"Consecutive single-institution case series of primary central nervous system lymphoma treated by R-MPV or high-dose methotrexate monotherapy","volume":"50","author":"Sasaki","year":"2020","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jocn.2026.111997_b0100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/10428194.2020.1821007","article-title":"Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV\/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy","volume":"62","author":"Tatarczuch","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"Pt 9","key":"10.1016\/j.jocn.2026.111997_b0105","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/brain\/awn146","article-title":"Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database","volume":"131","author":"Nestor","year":"2008","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jocn.2026.111997_b0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/neuonc\/nox150","article-title":"Brain volume reduction after whole-brain radiotherapy: quantification and prognostic relevance","volume":"20","author":"Hoffmann","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2026.111997_b0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbi.2021.12.026","article-title":"Chronic IL-10 overproduction disrupts microglia-neuron dialogue similar to aging, resulting in impaired hippocampal neurogenesis and spatial memory","volume":"101","author":"Sanchez-Molina","year":"2022","journal-title":"Brain Behav Immun"},{"issue":"7","key":"10.1016\/j.jocn.2026.111997_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/biom10071017","article-title":"The Regulatory Role of IL-10 in Neurodegenerative Diseases","volume":"10","author":"Porro","year":"2020","journal-title":"Biomolecules"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826001487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826001487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:48:51Z","timestamp":1776685731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586826001487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":24,"alternative-id":["S0967586826001487"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2026.111997","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes and MRI-based neurotoxicity assessment of elderly primary CNS lymphoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2026.111997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111997"}}